| PINK1 | |
|---|---|
| Gene | PINK1 |
| UniProt | Q9BXM7 |
| PDB | 6EQI, 7JZZ |
| Mol. Weight | 63 kDa (full-length), 52 kDa (processed) |
| Localization | Mitochondrial outer membrane |
| Family | Serine/threonine kinase family |
| Diseases | Parkinson's Disease |
Pink1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
PINK1 (PTEN-induced kinase 1) is a 63 kDa serine/threonine-protein kinase encoded by the PINK1 gene on chromosome 1p36. Originally identified as a gene upregulated by PTEN tumor suppressor, PINK1 has emerged as a critical regulator of mitochondrial quality control through its role in mitophagy. Loss-of-function mutations in PINK1 cause autosomal recessive early-onset Parkinson's disease, highlighting its essential role in dopaminergic neuron survival. PINK1 works in concert with the E3 ubiquitin ligase Parkin to identify and eliminate damaged mitochondria, a process essential for neuronal metabolic homeostasis and survival.
PINK1 contains several functional domains:
N-terminal mitochondrial targeting sequence (MTS) — Residues 1-34, amphipathic helix directing mitochondrial import
Transmembrane anchor — Residues 94-110, anchors protein in mitochondrial outer membrane (TOM)
Kinase domain — Residues 150-359, serine/threonine kinase core with ATP-binding pocket
C-terminal regulatory region — Residues 360-581, autoregulatory domain
PINK1 serves as the primary sensor of mitochondrial health:
Mitochondrial membrane potential monitoring
Phosphorylation reactions
PINK1 recruits and activates Parkin through:
The PINK1-Parkin pathway executes:
Loss of mitophagy function
Dysregulated mitochondrial dynamics
Enhanced apoptosis
PINK1 pathway activity can be assessed through:
Pink1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Pink1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Valente EM, Hereditary early-onset Parkinson's disease caused by mutations in PINK1, Science (2004)
Matsuda N, Phosphorylation of p62 is essential for PINK1-Parkin mitophagy, Autophagy (2017)
Kane LA, PINK1 phosphorylates ubiquitin to activate parkin mitophagy, Nature (2014)
Nguyen TN, Atg8 family LC3/GABARAP system in autophagy, J Mol Neurosci (2016)
Schulze-Rogers R, Structure of PINK1 and mechanisms of Parkinson's disease, EMBO Rep (2016)